Patents by Inventor William D. Kerns

William D. Kerns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS
    Publication number: 20220184007
    Abstract: Provided herein are high-dose formulations of acamprosate in a pharmaceutically acceptable salt form, as well as methods of preparing the same, and methods of using the same.
    Type: Application
    Filed: April 2, 2020
    Publication date: June 16, 2022
    Applicant: Synchroneuron Inc.
    Inventors: Barry S. Fogel, William D. Kerns, DVM, MS, DACVP, Kei-Lai Fong
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20200061003
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations optionally in combination with at least one other medication, and to combination products and compositions comprising acamprosate and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: April 4, 2019
    Publication date: February 27, 2020
    Inventors: Barry S. Fogel, William D. Kerns
  • Methods of treating posttraumatic stress disorder with acamprosate salts
    Patent number: 10512621
    Abstract: Embodiments disclosed herein generally relate to methods of treating posttraumatic stress disorder (PTSD) using acamprosate formulations and/or acamprosate formulations in combination with at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: December 24, 2019
    Assignee: Synchroneuron, Inc.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong
  • Acamprosate formulations, methods of using the same, and combinations comprising the same
    Patent number: 10166207
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations optionally in combination with at least one other medication, and to combination products and compositions comprising acamprosate and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: January 1, 2019
    Assignee: Synchroneuron, Inc.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20170042839
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: July 15, 2016
    Publication date: February 16, 2017
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong
  • Acamprosate formulations, methods of using the same, and combinations comprising the same
    Patent number: 9427420
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: August 30, 2016
    Assignee: Synchroneuron, Inc.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong, San-Laung Chow, Edward Lin, David Wong
  • Acamprosate formulations, methods of using the same, and combinations comprising the same
    Patent number: 9421179
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Grant
    Filed: May 9, 2013
    Date of Patent: August 23, 2016
    Assignee: Synchroneuron, Inc.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong
  • Acamprosate formulations, methods of using the same, and combinations comprising the same
    Patent number: 9421178
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Grant
    Filed: May 9, 2013
    Date of Patent: August 23, 2016
    Assignee: Synchroneuron, Inc.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20160101075
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations optionally in combination with at least one other medication, and to combination products and compositions comprising acamprosate and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: June 5, 2014
    Publication date: April 14, 2016
    Applicant: SYNCHRONEURON, INC.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong, San-Laung Chow, David Wong, Edward Lin
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20160081938
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations optionally in combination with at least one other medication, and to combination products and compositions comprising acamprosate and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: December 4, 2015
    Publication date: March 24, 2016
    Inventors: Barry S. Fogel, William D. Kerns
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20150250746
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: May 21, 2015
    Publication date: September 10, 2015
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong, San-Laung Chow, David Wong, Edward Lin
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20150119383
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: June 5, 2014
    Publication date: April 30, 2015
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong, San-Laung Chow, Edward Lin, David Wong
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20130245004
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: May 9, 2013
    Publication date: September 19, 2013
    Applicant: Synchroneuron Inc.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong
  • Administration of an anti-endotoxin drug by intravenous infusion
    Publication number: 20030130212
    Abstract: The invention provides methods for administering an anti-endotoxin drug, E5564, by intravenous infusion. The methods can be used for treating conditions such as endotoxemia, sepsis, and septic shock.
    Type: Application
    Filed: June 13, 2002
    Publication date: July 10, 2003
    Inventors: Daniel P. Rossignol, Melvyn Lynn, William D. Kerns
  • Methods for the treatment of hyperlipidemia using azaspiranes
    Patent number: 5455247
    Abstract: Invented is a method of treatment of hyperlipidemia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective therefor amount of a substituted azaspirane.
    Type: Grant
    Filed: April 22, 1994
    Date of Patent: October 3, 1995
    Assignee: SmithKline Beecham Corporation
    Inventors: Peter J. Bugelski, William D. Kerns